Researcher.Life Logo

Clinical and Experimental Hypertension : Impact Factor & More

eISSN: 1525-6006pISSN: 1064-1963
JournalOpen Access

Key Metrics

CiteScore
3.2
Impact Factor
10 - 15
SNIP
0.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Experimental Hypertension

Clinical and Experimental Hypertension Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Bi-monthly
Article Processing ChargesGBP 1880 | USD 2390 | EUR 2180 | AUD 3265
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1978
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Clinical and Experimental Hypertension ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Experimental Hypertension

Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Dissecting burden of alcoholic cardiomyopathy: age-period-cohort analysis from the global burden of disease study 2019
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.
  • 31 Dec 2026
  • Clinical and experimental hypertension (New York, N.Y. : 1993)
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Elevated circulating unsaturated fatty acids: A novel metabolic feature of coronary artery disease without traditional risk factors
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Inflammatory mechanisms and targeted drugs in heart failure
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Dissecting burden of alcoholic cardiomyopathy: age-period-cohort analysis from the global burden of disease study 2019
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Frailty as a mediator of the association between hyperuricemia and stroke risk: A prospective cohort study.
  • 31 Dec 2026
  • Clinical and experimental hypertension (New York, N.Y. : 1993)
Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Elevated circulating unsaturated fatty acids: A novel metabolic feature of coronary artery disease without traditional risk factors
  • 31 Dec 2026
  • Clinical and Experimental Hypertension
Inflammatory mechanisms and targeted drugs in heart failure
  • 31 Dec 2026
  • Clinical and Experimental Hypertension

FAQs on Clinical and Experimental Hypertension